Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Physiomics (PYC) by Steve Moore in ShareProphets
- Avoid Pinewood Technologies Group (PINE) by Steve Moore in ShareProphets
- Underweight HGCapital Trust (HGT) by JP Morgan
- Avoid Beeks Financial Cloud Group (BKS) by Steve Moore in ShareProphets
- Buy Helios Towers (HTWS) by Bank of America
- Buy Barclays (BARC) by Bank of America
- Add AstraZeneca (AZN) by Simon Watkins in The Motley Fool
- Buy NATWEST GROUP (NWG) by Simon Watkins in The Motley Fool
- Hold InterContinental Hotels Group (IHG) by Peel Hunt
- Hold Ecora Resources (ECOR) by Peel Hunt
- Buy Applied Nutrition (APN) by Berenberg
- Hold Unilever (ULVR) by HSBC
- Neutral Airtel Africa (AAF) by Goldman Sachs
- Overweight Glanbia (CDI) (GLB) by Barclays
- Neutral AIB Group (CDI) (AIBG) by Goldman Sachs
- Hold GSK (GSK) by Berenberg
- Equal Weight Schroders (SDR) by Morgan Stanley
- Buy SSP Group (SSPG) by UBS
- Buy RS Group (RS1) by John Ficenec in The Times - Tempus
- Avoid Celebrus Technologies (CLBS) by Steve Moore in ShareProphets
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 63 open tips for Avacta Group (AVCT)
| Latest Bid : 55.00p | Latest Ask : 57.00p |
| High Today : 57.00p | Low Today : 54.45p |
| This Years High : 82.50p | This Years Low : 27.50p |
| Volume : 504,861 | MKT Cap : £206.64M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2022-06-13 10:05:00 13/06/2022 | 72.68% |
| Avoid | Zaven Boyrazian | Premium Only | 2022-03-24 13:30:00 24/03/2022 | 29.72% |
| Avoid | Andrew Woods | Premium Only | 2022-03-01 15:05:00 01/03/2022 | 14.13% |
| Hold | Richard Evans | Premium Only | 2022-01-12 07:50:00 12/01/2022 | -33.33% |
| Sell | Tom Winnifrith | Premium Only | 2022-01-10 13:35:00 10/01/2022 | 41.71% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 55.00p | Latest Ask : 57.00p |
| High Today : 57.00p | Low Today : 54.45p |
| This Years High : 82.50p | This Years Low : 27.50p |
| Volume : 504,861 | MKT Cap : £206.64M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Tom Winnifrith | Premium Only | 2022-06-13 10:05:00 13/06/2022 | 72.68% |
| Avoid | Zaven Boyrazian | Premium Only | 2022-03-24 13:30:00 24/03/2022 | 29.72% |
| Avoid | Andrew Woods | Premium Only | 2022-03-01 15:05:00 01/03/2022 | 14.13% |
| Hold | Richard Evans | Premium Only | 2022-01-12 07:50:00 12/01/2022 | -33.33% |
| Sell | Tom Winnifrith | Premium Only | 2022-01-10 13:35:00 10/01/2022 | 41.71% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000